Profil
Eric Jason Edidin was the founder of Archer Capital Management LP, founded in 2005, serving as Managing Partner from 2005 to 2019.
Mr. Edidin is the founder of Endo Investors, founded in 2013, serving as President since 2013.
Mr. Edidin is the founder of Council Advisors Capital Corp., founded in 2020, serving as Co-Chief Executive Officer since 2020.
Current jobs include Executive Chairman at BH3 Management LLC since 2020; Director at Diasome Pharmaceuticals, Inc.; Director at The Jewish Federation Council of Greater Los Angeles; Independent Director at Spartacus Acquisition Corp.
II starting in 2026; Director at Cecelia Health, Inc. since 2019; Director at ILiAD Biotechnologies LLC since 2020; Director at Mellitus Health, Inc.; and Director at Cecelia Health Holdings, Inc. Former jobs include Managing Director at York Capital Management Global Advisors LLC; Managing Director at York Capital Management LP; Director at Focus Impact BH3 Acquisition Co. from 2021 to 2023; Director at Begin a Legacy, Inc.; Independent Director at Spartacus Acquisition Corp.
(Georgia) from 2020 to 2022; Associate at Blackstone Corporate Private Equity; Associate at Morgan Stanley & Co. LLC; and Trustee at Jewish Communal Fund.
Education includes an undergraduate degree from the University of Michigan in 1993 and an MBA from Harvard Business School.
Postes actifs de Eric Edidin
| Sociétés | Poste | Début |
|---|---|---|
Mellitus Health, Inc.
Mellitus Health, Inc. Packaged SoftwareTechnology Services Develops insulin titration software | Directeur/Membre du Conseil | - |
Endo Investors
Endo Investors Investment ManagersFinance Endo Investors invests in companies located in the United States. The firm targets companies operating in Life Science Ventures, diabetes and other major global health issues. It provides financing to early stage transactions. | Fondateur | 01/01/2013 |
Cecelia Health Holdings, Inc.
Cecelia Health Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
BH3 Management LLC
BH3 Management LLC Investment ManagersFinance BH3 Management LLC is an active manager. | Président | 01/01/2020 |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology Operates as clinical stage biotechnology company that focuses on prevention and treatment of disease caused by bordetella pertussis | Directeur/Membre du Conseil | 01/02/2020 |
Cecelia Health, Inc.
Cecelia Health, Inc. Medical SpecialtiesHealth Technology Operates innovative diabetes platform across new customer channels | Directeur/Membre du Conseil | 01/09/2019 |
Council Advisors Capital Corp. | Directeur Général | 01/01/2020 |
The Jewish Federation Council of Greater Los Angeles
The Jewish Federation Council of Greater Los Angeles Services to the Health IndustryHealth Services Provides emergency relief and social services | Directeur/Membre du Conseil | - |
Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes | Directeur/Membre du Conseil | - |
Anciens postes connus de Eric Edidin
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Edidin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
York Capital Management Global Advisors LLC
York Capital Management Global Advisors LLC Investment ManagersFinance York is a global, event-driven investment firm which specializes in M&A transactions, distressed situations, restructuring opportunities and special situations including spin-offs and split-ups, litigation opportunities, shareholder agitation and proxy contests, balance sheet arbitrage and consolidations. The firm seeks to generate consistent superior investment results relatively independent of the returns generated by the overall equity markets. Their approach is opportunistic and builds portfolios from the bottom-up on a trade-by-trade basis in response to market conditions. | Finance |
Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes | Health Technology |
Blackstone Corporate Private Equity
Blackstone Corporate Private Equity Investment ManagersFinance Blackstone Corporate invests in middle market companies located across the globe. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout and growth stage capital requirements. | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Jewish Communal Fund
Jewish Communal Fund Services to the Health IndustryHealth Services Provides public charity services | Health Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Jewish Federation Council of Greater Los Angeles
The Jewish Federation Council of Greater Los Angeles Services to the Health IndustryHealth Services Provides emergency relief and social services | Health Services |
Archer Capital Management LP
Archer Capital Management LP Investment ManagersFinance Archer Capital Management (ACM) employs a middle-market distressed and special situation investment strategy by investing in a wide range of financial instruments and securities, including syndicated bank debt, high yield bonds, non-performing distressed fixed income securities, equities and convertible securities. In addition, the firm may invest in mortgage notes, trade claims, leases, privately-sourced bank debt, non-performing loan portfolios, and other equity and credit instruments. At certain times in the business cycle, ACM may target investments in distressed securities where ownership positions in enterprises can be created at significant discounts to long-term intrinsic value and active involvement in restructuring may be used as a catalyst to value realization. Their clients may leverage their portfolios through margin and other debt. ACM may invest in foreign issuers and currencies. They also may invest in high yield bonds and preferred stocks, as well as securities in lower rating categories and in unrated securities. The objective of the funds managed by ACM is to achieve superior risk-adjusted returns over the business cycle primarily by investing in middle-market distressed and special situations debt and equity securities. The investment objectives and restrictions of the funds may vary by target position sizes, portfolio concentration and exposures, projected holding periods and other factors. ACM's objectives, strategies and policies may evolve over time based on conditions and trends in the financial and securities markets and the economy in general. | Finance |
York Capital Management LP
York Capital Management LP Investment Trusts/Mutual FundsMiscellaneous Functions as a hedge fund | Miscellaneous |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cecelia Health, Inc.
Cecelia Health, Inc. Medical SpecialtiesHealth Technology Operates innovative diabetes platform across new customer channels | Health Technology |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology Operates as clinical stage biotechnology company that focuses on prevention and treatment of disease caused by bordetella pertussis | Health Technology |
Begin a Legacy, Inc.
Begin a Legacy, Inc. Packaged SoftwareTechnology Services Develops software application that allows individuals and companies to start and run a nonprofit | Technology Services |
BH3 Management LLC
BH3 Management LLC Investment ManagersFinance BH3 Management LLC is an active manager. | Finance |
Mellitus Health, Inc.
Mellitus Health, Inc. Packaged SoftwareTechnology Services Develops insulin titration software | Technology Services |
Cecelia Health Holdings, Inc.
Cecelia Health Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Endo Investors
Endo Investors Investment ManagersFinance Endo Investors invests in companies located in the United States. The firm targets companies operating in Life Science Ventures, diabetes and other major global health issues. It provides financing to early stage transactions. | Finance |
Spartacus Acquisition Corp. (Georgia)
Spartacus Acquisition Corp. (Georgia) Financial ConglomeratesFinance Operates as a blank check company | Finance |
Council Advisors Capital Corp. | |
Crixus BH3 Acquisition Co.
Crixus BH3 Acquisition Co. Financial ConglomeratesFinance Operates as a blank check company | Finance |
















